Association Study of Serotonin 3 Receptor Subunit Gene Variants in Antipsychotic-Induced Weight Gain

被引:3
作者
Zai, Clement C. [1 ,2 ,3 ]
Tiwari, Arun K. [1 ,2 ]
Chowdhury, Nabilah I. [1 ]
Brandl, Eva J. [1 ,2 ,4 ]
Shaikh, Sajid A. [1 ]
Freeman, Natalie [1 ]
Lieberman, Jeffrey A. [5 ,6 ]
Meltzer, Herbert Y. [7 ]
Kennedy, James L. [1 ,2 ]
Mueller, Daniel J. [1 ,2 ]
机构
[1] Univ Toronto, Neurogenet Sect, Campbell Family Mental Hlth Res Inst, Ctr Addict & Mental Hlth, Toronto, ON, Canada
[2] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[3] Univ Toronto, Lab Med & Pathobiol, Toronto, ON, Canada
[4] Charite Univ Med Berlin, Dept Psychiat & Psychotherapy, Berlin, Germany
[5] Columbia Univ, New York State Psychiat Inst, Coll Phys & Surg,New York Presbyterian Hosp, Dept Psychiat,Lieber Ctr Schizophrenia Res, New York, NY USA
[6] Columbia Univ, Med Ctr, New York, NY USA
[7] Northwestern Univ, Dept Psychiat & Beh Sci, Feinberg Sch Med, Chicago, IL 60611 USA
基金
美国国家卫生研究院; 加拿大健康研究院;
关键词
Serotonin 3A and 3B receptor genes (HTR3A; HTR3B); Schizophrenia; Antipsychotic-induced weight gain; Pharmacogenetics; 5-HT3; ANTAGONIST; SCHIZOPHRENIA; CLOZAPINE; COMMON; PHARMACOGENETICS; ONDANSETRON; HOMEOSTASIS;
D O I
10.1159/000457903
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Schizophrenia (SCZ) is a chronic severe neuropsychiatric disorder, where pharmacological treatment has been hindered by adverse effects, including antipsychotic-induced weight gain (AIWG) and related complications. Genetic studies have been exploring the appetite regulation and energy homeostasis pathways in AIWG with some promising leads. The serotonin system has been shown to participate in these pathways. Methods: In the current study, we examined single nucleotide polymorphisms across the serotonin receptor genes HTR3A and HTR3B. Prospective weight change was assessed for a total of 149 SCZ patients of European ancestry. Results: We did not find the tested HTR3A or HTR3B gene markers to be associated with AIWG in our sample. Conclusion: Our preliminary findings suggest that these receptors may not play a major role in predicting AIWG. (C) 2017 S. Karger AG, Basel
引用
收藏
页码:169 / 175
页数:7
相关论文
共 38 条
  • [1] Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research
    Arranz, M. J.
    de Leon, J.
    [J]. MOLECULAR PSYCHIATRY, 2007, 12 (08) : 707 - 747
  • [2] Haploview: analysis and visualization of LD and haplotype maps
    Barrett, JC
    Fry, B
    Maller, J
    Daly, MJ
    [J]. BIOINFORMATICS, 2005, 21 (02) : 263 - 265
  • [3] Genetic association study between antipsychotic-induced weight gain and the melanocortin-4 receptor gene
    Chowdhury, N. I.
    Tiwari, A. K.
    Souza, R. P.
    Zai, C. C.
    Shaikh, S. A.
    Chen, S.
    Liu, F.
    Lieberman, J. A.
    Meltzer, H. Y.
    Malhotra, A. K.
    Kennedy, J. L.
    Mueller, D. J.
    [J]. PHARMACOGENOMICS JOURNAL, 2013, 13 (03) : 272 - 279
  • [4] Genetics of second-generation antipsychotic and mood stabilizer-induced weight gain in bipolar disorder: common and specific effects of key regulators of fat-mass homoeostasis genes
    Creta, Elia
    Fabbri, Chiara
    Serretti, Alessandro
    [J]. PHARMACOGENETICS AND GENOMICS, 2015, 25 (07) : 354 - 362
  • [5] Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data
    Dudbridge, Frank
    [J]. HUMAN HEREDITY, 2008, 66 (02) : 87 - 98
  • [6] Endicott J, 2001, AM J MED GENET, V105, P48, DOI 10.1002/1096-8628(20010108)105:1<48::AID-AJMG1057>3.0.CO
  • [7] 2-M
  • [8] Ondansetron reduces nausea induced by gastroduodenal stimulation without changing gastric motility
    Feinle, C
    Read, NW
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1996, 271 (04): : G591 - G597
  • [9] First MB., 1996, Structured clinical interview for DSM-IV axis II personality disorders (SCID II), DOI DOI 10.1037/T07827-000
  • [10] Body weight gain induced by atypical antipsychotics: an extension of the monocygotic twin and sib pair study
    Gebhardt, S.
    Theisen, F. M.
    Haberhausen, M.
    Heinzel-Gutenbrunner, M.
    Wehmeier, P. M.
    Krieg, J. -C.
    Kuehnau, W.
    Schmidtke, J.
    Remschmidt, H.
    Hebebrand, J.
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2010, 35 (02) : 207 - 211